Literature DB >> 19733469

Respiratory movement of upper abdominal organs and its effect on radiotherapy planning in pancreatic cancer.

S Gwynne1, L Wills, G Joseph, G John, J Staffurth, C Hurt, S Mukherjee.   

Abstract

AIMS: Radiotherapy for pancreatic cancer is complicated by the frequent overlapping of the planning target volume (PTV) and the organ at risk (OAR), limiting the dose that can be safely delivered to the tumour. Individualising the margins applied to the clinical target volume (CTV) may reduce OAR irradiation without increasing the risk of geographical miss. We quantified the movement of the pancreas with respiration and evaluated whether individualised margins based on this motion reduced the dose to OARs.
MATERIALS AND METHODS: Planning computed tomography scans were acquired in quiet breathing, held expiration and held inspiration. Organ motion was evaluated from displacement of a reproducible point within the pancreas in all directions. Two sets of plans (standard plan: P(stan); individualised plan incorporating movement data: P(ind)) were generated for each patient. The PTV and doses to OARs were evaluated for both sets of plans.
RESULTS: The mean (standard deviation) movement of the pancreas in the superior-inferior, lateral and anterior-posterior directions were 15.3 mm (4.3), 5.2 mm (3.5) and 9.7 mm (6.1), respectively. The use of individualised margins reduced the mean PTV volume by 33.5% (9.8) (P=0.0051). The proportional reductions in the percentage of kidney receiving >10 Gy, small bowel >45 Gy and liver >30 Gy were 63.7% (P=0.0051), 29.3% (P=0.0125) and 29.2% (P=0.0107), respectively. For the same level of OAR constraints, individualised margins allowed dose escalation in six of the 10 patients to a mean dose of 63.2 Gy.
CONCLUSIONS: The present study shows a simple way of incorporating organ motion into the planning process and can be adopted by any centre without major strain on healthcare resources. The use of individualised margins reduced PTV volume and the dose to OARs. This may offer an opportunity for dose escalation to try and further improve local control.

Entities:  

Mesh:

Year:  2009        PMID: 19733469     DOI: 10.1016/j.clon.2009.07.015

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  13 in total

Review 1.  Neoadjuvant radiotherapeutic strategies in pancreatic cancer.

Authors:  Falk Roeder
Journal:  World J Gastrointest Oncol       Date:  2016-02-15

Review 2.  Motion management in gastrointestinal cancers.

Authors:  Hassan Abbas; Bryan Chang; Zhe Jay Chen
Journal:  J Gastrointest Oncol       Date:  2014-06

3.  Feasibility of automated pancreas segmentation based on dynamic MRI.

Authors:  S Gou; J Wu; F Liu; P Lee; S Rapacchi; P Hu; K Sheng
Journal:  Br J Radiol       Date:  2014-10-01       Impact factor: 3.039

4.  Assessment of respiration-induced displacement of canine abdominal organs in dorsal and ventral recumbency using multislice computed tomography.

Authors:  Cintia R Oliveira; Margaret A Henzler; Rebecca A Johnson; Randi Drees
Journal:  Vet Radiol Ultrasound       Date:  2014-08-18       Impact factor: 1.363

5.  Reproducibility of diaphragm position assessed with a voluntary breath-holding device.

Authors:  Shigeyuki Takamatsu; Tsuyoshi Takanaka; Tomoyasu Kumano; Eiichi Mizuno; Satoshi Shibata; Shizuko Ohashi; Yuichi Kurata; Shinichi Ueda; Naoki Hori; Saori Shouji; Kimiya Noto; Hironori Kojima; Osamu Matsui
Journal:  Jpn J Radiol       Date:  2013-03-23       Impact factor: 2.374

6.  Dosimetric and radiobiological impact of abdominal compression on adjacent gastro-intestinal critical structures for patients treated with upper and mid-abdominal stereotactic body radiotherapy.

Authors:  Soumyajit Roy; Svetlana Kuznetsova; Kundan Thind; Petra Grendarova; Nicolas Ploquin; Richie S Sinha
Journal:  J Radiosurg SBRT       Date:  2019

7.  Prognostic value of gross tumor volume delineated by FDG-PET-CT based radiotherapy treatment planning in patients with locally advanced pancreatic cancer treated with chemoradiotherapy.

Authors:  Cem Parlak; Erkan Topkan; Cem Onal; Mehmet Reyhan; Ugur Selek
Journal:  Radiat Oncol       Date:  2012-03-19       Impact factor: 3.481

8.  Feasibility and early clinical assessment of flattening filter free (FFF) based stereotactic body radiotherapy (SBRT) treatments.

Authors:  Marta Scorsetti; Filippo Alongi; Simona Castiglioni; Alessandro Clivio; Antonella Fogliata; Francesca Lobefalo; Pietro Mancosu; Pierina Navarria; Valentina Palumbo; Chiara Pellegrini; Sara Pentimalli; Giacomo Reggiori; Anna M Ascolese; Antonella Roggio; Stefano Arcangeli; Angelo Tozzi; Eugenio Vanetti; Luca Cozzi
Journal:  Radiat Oncol       Date:  2011-09-12       Impact factor: 3.481

9.  Intensity modulated radiotherapy of upper abdominal malignancies: dosimetric comparison with 3D conformal radiotherapy and acute toxicity.

Authors:  Alaa Ahmad Nour; Aziz Alaradi; Adel Mohamed; Saleh Altuwaijri; Volker Rudat
Journal:  Radiat Oncol       Date:  2013-09-05       Impact factor: 3.481

10.  Feasibility of automated 3-dimensional magnetic resonance imaging pancreas segmentation.

Authors:  Shuiping Gou; Percy Lee; Peng Hu; Jean-Claude Rwigema; Ke Sheng
Journal:  Adv Radiat Oncol       Date:  2016-05-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.